Empire Biotechnologies is a therapeutics company developing therapies for diseases with significant unmet medical needs.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: San Francisco
State: California
Zip:
Country: United States
Empire Biotechnologies is developing an orally delivered, protein therapeutic called Mfge8 to treat diseases of malabsorption. It aims to develop and promote technologies that will bring positive change to the world. Empire Biotechnologies was formed in 2013 to execute its goal of commercializing platform technologies currently under development at the SUNY College of Nanoscale Science and Engineering and the University of California San Francisco.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Seed Round | 1 | $100k |
Berkeley SkyDeck Fund Berkeley SkyDeck Fund |
5/2018 | Seed Round | $800k | 11/2016 | Convertible Note | $240k | 3/2019 | Non Equity Assistance | 1 | - |
SkyDeck Berkeley SkyDeck Berkeley |
3/2019 | Non Equity Assistance | 1 | - |
SkyDeck Berkeley SkyDeck Berkeley |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|